Literature DB >> 20834207

Benign cardiac tumors: a review.

Brian A Bruckner1, Michael J Reardon.   

Abstract

Tumors of the heart are very uncommon and can occur as primary or secondary metastatic tumors. Metastatic tumors are over 40 times more common than primary cardiac tumors. Primary tumors of the heart are benign in 75% of cases and malignant in 25%. We first reported our institutional experience with all primary cardiac tumors in 2003. Of the 85 patients seen, 17 had malignant tumors (20%) and 68 had benign tumors (80%). These benign tumors and our subsequent experience form the basis of this report.

Entities:  

Mesh:

Year:  2010        PMID: 20834207     DOI: 10.14797/mdcj-6-3-20

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  5 in total

Review 1.  Evaluation and Management of Cardiac Tumors.

Authors:  Nicolas Palaskas; Kara Thompson; Gregory Gladish; Ali M Agha; Saamir Hassan; Cezar Iliescu; Peter Kim; Jean B Durand; Juan C Lopez-Mattei
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

2.  Cardiac Papillary Fibroelastoma: Single-Institution Experience with 14 Surgical Patients.

Authors:  Walid K Abu Saleh; Odeaa Al Jabbari; Basel Ramlawi; Michael J Reardon
Journal:  Tex Heart Inst J       Date:  2016-04-01

Review 3.  Minimally invasive resection of benign cardiac tumors.

Authors:  Ayman Kenawy; Abdelrahman Abdelbar; Joseph Zacharias
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

4.  Double valve involvement: papillary fibroelastoma in a patient with severe mitral and aortic valve regurgitation.

Authors:  Oyintayo Ajiboye; Jan Michael Racoma; Kifah Hussain; Benjamin Mba
Journal:  BMJ Case Rep       Date:  2020-07-16

5.  Epicardial carvernous hemangioma: The diagnostic challenge of a middle mediastinal mass.

Authors:  Gabrielle Drevet; Lara Chalabreysse; Delphine Gamondes; François Tronc; Jean-Michel Maury
Journal:  Thorac Cancer       Date:  2021-07-20       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.